SCL expression at critical points in human hematopoietic lineage commitment

Stem Cells

Volumn 23, Issue 6, 2005, Pages 852-860

  Zhang, Yanjia ^a   Payne, Kimberly J ^a   Zhu, Yuhua ^a   Price, Mary A ^b   Parrish, Yasmin K ^a   Zielinska, Ewa ^a   Barsky, Lora W ^a   Crooks, Gay M ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Erythropoiesis; Hematopoietic progenitors; Leukemia; Transcription factors

Indexed keywords

GENE PRODUCT; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 1;

ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL POPULATION; COLONY FORMATION; ERYTHROID CELL; FLUORESCENCE ACTIVATED CELL SORTING; GENE TARGETING; GENE TRANSLOCATION; GRANULOCYTE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKEMIA CELL; MEGAKARYOCYTE; MONOCYTE; NATURAL KILLER CELL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTIGENS, CD34; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; CELL SEPARATION; CELLS, CULTURED; DNA-BINDING PROTEINS; DOWN-REGULATION; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; MICE; MODELS, BIOLOGICAL; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEM CELLS; THYMUS GLAND; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 20344396856     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2004-0260     Document Type: Article

References (35)

1. Begley CG, Aplan PD, Denning SM et al. The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. Proc Natl Acad Sci U S A 1989;86:10128-10132.
2. Apian PD, Lombardi DP, Ginsberg AM et al. Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity. Science 1990;250:1426-1429.
3. Bernard O, Guglielmi P, Jonveaux P et al. Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T-cell leukemias. Genes Chromosomes Cancer 1990;1:1194-208.
4. Chen Q, Yang CY, Tsan JT et al. Coding sequences of the tal-1 gene are disrupted by chromosome translocation in human T cell leukemia. J Exp Med 1990;172:1403-1408.
5. Brown L, Cheng JT, Chen Q et al. Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia. EMBO J 1990;9:3343-3351.
6. Bernard O, Lecointe N, Jonveaux P et al. Two site-specific deletions and t(1;14) translocation restricted to human T-cell acute leukemias disrupt the 5′ part of the tal-1 gene. Oncogene 1991;6:1477-1488.
7. Hsu HL, Cheng JT, Chen Q et al. Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins. Mol Cell Biol 1991;11:3037-3042.
8. Voronova AF, Lee F. The E2a and tal-1 helix-loop-helix proteins associate in vivo and are modulated by id proteins during interleukin 6-induced myeloid differentiation. Proc Natl Acad Sci U S A 1994;91:5952-5956.
9. Zhao XF, Aplan PD. The hematopoietic transcription factor SCL binds the p44 subunit of TFIIH. J Biol Chem 1999;274:1388-1393.
10. Wadman IA, Osada H, Grutz GG et al. The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the Ta111, E47, Gata-1 and Ldb1/NLI proteins. EMBO J 1997;16:3145-3157.
11. Lecuyer E, Herblot S, Saint-Denis M et al. The SCL complex regulates c-kit expression in hematopoietic cells through functional interaction with Sp1. Blood 2002;100:2430-2440.
12. Robb L, Lyons I, Li R et al. Absence of yolk sac hematopoiesis from mice with a targeted disruption of the SCL gene. Proc Natl Acad Sci U S A 1995;92:7075-7079.
13. Shivdasani RA, Mayer EL, Orkin SH. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/ScL. Nature 1995;373:432-434.
14. Robb L, Elwood NJ, Elefanty AG et al. The SCL gene product is required for the generation of all hematopoietic lineages in the adult mouse. EMBO J1996;15:4123-4129.
15. Porcher C, Swat W, Rockwell K et al. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell 1996;86:47-57.
16. Mikkola HK, Klintman J, Yang H et al. Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene. Nature 2003;421:547-551.
17. Hall MA, Curtis DJ, Metcalf D et al. The critical regulator of embryonic hematopoiesis, SCL, is vital in the adult for megakaryopoiesis, erythropoiesis, and lineage choice in cfu-s12. Proc Natl Acad Sci U S A 2003;100:992-997.
18. Curtis DJ, Hall MA, Van Stekelenburg LJ et al. SCL is required for normal function of short-term repopulating hematopoietic stem cells. Blood 2004;103:3342-3348.
19. Kunisato A, Chiba S, Saito T et al. Stem cell leukemia (SCL) directs hematopoietic stem cell fate. Blood 2004;103:3336-3341.
20. Condorelli GL, Tocci A, Botta R et al. Ectopic tal-1/SCL expression in phenotypically normal or leukemic myeloid precursors: Proliferative and antiapoptotic effects coupled with a differentiation blockade. Mol Cell Biol 1997;17:2954-2969.
21. Leroy-Viard K, Vinit MA, Lecointe N et al. Loss of TAL-1 protein activity induces premature apoptosis of jurkat leukemic T cells upon medium depletion. EMBO J 1995;14:2341-2349.
22. Elwood NJ, Cook WD, Metcalf D et al. SCL, the gene implicated in human T-cell leukaemia, is oncogenic in a murine T-lymphocyte cell line. Oncogene 1993;8:3093-3101.
23. Tanigawa T, Robb L, Green AR et al. Constitutive expression of the putative transcription factor SCL associated with proviral insertion in the myeloid leukemic cell line WEHI3BD. Cell Growth Differ 1994;5:557-561.
24. Apian PD, Nakahara K, Orkin SH et al. The SCL gene product: A positive regulator of erythroid differentiation. EMBO J 1992;11:4073-4081.
25. Ravet E, Reynaud D, Titeux M et al. Characterization of DNA-binding dependent and independent functions of SCL/TAL1 during human erythropoiesis. Blood 2004;103:3326-3335.
26. Valtieri M, Tocci A, Gabbianelli M et al. Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program. Cancer Res 1998;58:562-569.
27. + cells: Consequence of enforced expression of SCL. Blood 1998;91:3756-3765.
28. Condorelli G, Vitelli L, Valtieri M et al. Coordinate expression and developmental role of id2 protein and TAL1/E2A heterodimer in erythroid progenitor differentiation. Blood 1995;86:164-175.
29. Hao QL, Zhu J, Price MA et al. Identification of a novel, human multilymphoid progenitor in cord blood. Blood 2001;97:3683-3690.
30. - cells in cord blood and bone marrow. Blood 1995;86:3745-3753.
31. Nakahata T, Okumura N. Cell surface antigen expression in human erythroid progenitors: Erythroid and megakaryocytic markers. Leuk Lymphoma 1994;13:401-409.
32. Manz MG, Miyamoto T, Akashi K et al. Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci U S A 2002;99:11872-11877.
33. Mouthon MA, Bernard O, Mitjavila MT et al. Expression of tal-1 and Gata-binding proteins during human hematopoiesis. Blood 1993;81:647-655.
34. + erythroid progenitors: Temporal changes in gene and protein expression. Exp Hematol 2003;31:760-769.
35. Lahlil R, Lecuyer E, Herblot S et al. Scl assembles a multifactorial complex that determines glycophorin S expression. Mol Cell Biol 2004;24:1439-1452.